You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
環亞國際實業(01143.HK)獲550萬美元新冠病毒檢測試劑盒產品訂單
格隆匯 03-19 21:54

格隆匯3月19日丨環亞國際實業(01143.HK)發佈公告,繼2020年3月16日,公司取得上海伯傑醫療有限公司的新冠病毒(COVID-19)檢測試劑盒相關產品在歐洲五國獨家代理銷售權及其它國家非獨家代理銷售權後,管理層基於在上述區域積累的渠道資源,積極推廣此試劑盒產品且於短時間內取得良好進展。

公告稱,公司於3月19日與Brisk Success Holdings Limited (“Brisk Success”)簽署了銷售合同。根據此銷售合同,Brisk Success同意向公司採購新冠病毒( COVID -19 )檢測試劑盒產品,訂單金額為550萬美元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account